semaglutide atrial fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies Semaglutide use in patients undergoing

The results demonstrated no significant difference in the risk of death from any cause between patients receiving and not receiving statins in the overall analysis

Crowdsourcingbased knowledge graph construction for drug side effects using large language models with an application on semaglutide

The authors of the analysis also recommended exploring if the weight loss that occurs on semaglutide drugs may contribute to the formation of blood clots

This can lead to a gradual loss of bacteriostatic potency over time

Andrew Lee, clinical spokesperson for the American Academy of Ophthalmology and a neuro-ophthalmologist at Houston Methodist Hospital, said he's had some patients who developed NAION who were taking semaglutide, but the question was always whether this is a causal association or merely an association alone. People with Type 2 diabetes are already at an increased risk for vision problems, including NAION

Peter McCullough is the most published doctor in his field in human history